Indonesia Market Today - 5 October 2020

A. INDONESIA MORNING MARKET REVIEW

Monday (05/10/2020). After DJIA had crashed by more than -400 points in the day`s range on Friday, but knowing that President Trump only suffered from "mild symptom" of Covid19, DJIA finally managed to recover and closed down -134 points (-0.48%) amid * Dow Futures this Monday morning strengthened of +134 points *. * Positive news also comes from the increasing number of issuers that provide Remdisivir, the Covid19 drug, (previously only KLBF through Covivor), now INAF will also provide Remdisivir drugs with the Desrem brand * so that the bright spot for healing patients infected with Covid19 is getting bigger before the anti-Covid19 vaccine is available in Indonesia . Meanwhile, from the commodity market only Nickel and Tin prices experienced an increase of + 0.09% & + 2.33% respectively, while investors need to be aware of the sharp fall in commodity prices: Oil -4.42%, Coal -1.79%, Gold -0.64% and CPO -2.71% amidst the attainment of the highest number of victims infected and killed due to Corvid19, where for 3 days (Friday - Sunday) there was an increase of around +12,316 people (up + 4.23%) infected with Corvid so that so far the victims infected with Corvid19 reached 303,498 people with the addition of the death toll for 3 days was +295 people (an increase of + 2.72%) so that so far the death toll has reached 11151 people. (Fatality Rate of 3.67%) *.

B. INDONESIA CORPORATE NEWS

1. PT Kalbe Farma (KLBF)

The company and PT Amarox Pharma Global lowered the price of the drug remdesivir with the Covifor trademark to Rp1.5 million per vial. Previously, the Covifor drug would be sold for IDR 3 million in Indonesia. The company added that the adjustment of the Covifor drug price after considering several things, starting from the development of the Covid-19 case in Indonesia, the need for remdesivir drug treatment for Covid-19, and especially input from the government, health workers and patients.

2. PT Medco Energi Internasional (MEDC)

As of semester 1/2020, the company posted revenues of US $ 551.76 million, down 7.56% yoy from semester I / 2019 valued at US $ 596.88 million. There are three main businesses that support this income. Net oil and gas sales worth US $ 470.68 million or Rp6.72 trillion, sales of electricity and related services US $ 79.31 million or Rp1.13 trillion, and service revenues of US $ 1.77 million or Rp25.28 billion. There was an increase in sales of electricity and services from the first semester of 2019 amounting to US $ 65.39 million and US $ 650,692, respectively. However, oil and gas sales as the main revenue contributor decreased from US $ 530.83 million. Meanwhile, until the end of semester 1/2020, the company recorded a loss for the current period attributable to the owners of the parent entity amounting to US $ 95.75 million or equivalent to Rp1.37 trillion. The net loss was reversed from the previous net profit of US $ 27.86 million in the first half of 2019.

3. PT Wijaya Karya Bangunan Gedung (WEGE)

The company is currently pursuing the acquisition of a new contract value whose realization is still 40% or around Rp. 1.4 trillion of the 2020 target of Rp. 3.4 trillion. This means that WEGE still has to catch up to IDR 2 trillion by the end of the year. The details of obtaining new contracts, the company still gets jobs dominated by private projects 43%, BUMN 32%, and the rest from the government.

4. PT Medikaloka Hermina (HEAL)

The company plans to conduct PMTHMETD or private placement to strengthen the capital structure of up to 10% or around 297,300,000 new shares with a nominal value of Rp100 or Rp29.73 billion. With the assumption that all shares can be issued in this PMTHMETD, the company`s shareholders will be subject to a dilution of their ownership by as much as 9.09%.

5. PT Dafam Property Indonesia (DFAM)

The company plans to launch two hotels this month. The Rp 800 billion investment for other projects is also continuing. The two 3-star hotels will be located in Makassar (South Sulawesi) and Jakarta.

6. PT Blue Bird (BIRD)

As a result of the impact of the Covid pandemic, the company estimates that there will be a decrease in revenue of around 25% to 50% this year from 2019. Meanwhile, BIRD`s net profit also has the potential to fall by more than 75%.

7. PT Sawit Sumbermas Sarana (SSMS)

Until semester 1/2020, the company posted revenue of IDR 1.77 trillion or grew 18.33% yoy from IDR 1.49 trillion in semester I / 2019. Meanwhile, until the end of semester 1/2020 the company posted a net profit of IDR 100.61 billion, or reversed from a net loss of IDR 15.01 billion at the end of June 2019.

C. MARKET STATISTICS

DJIA -134 -0.48% 27682
NASDAQ -251 -2.22% 11075
GOLD -12.20 -0.64% 1904.10
OIL -1.71 -4.42% 37.01
COAL (Okt/Newcastle) -1.05 -1.79% 57.55
*NICKEL +12.5 +0.09% 14330*
*TIN +407.5 +2.33% 17860*
CPO (Nov`) -77 -2.71% 2767
EIDO -0.29 -1.64% 17.41
*TLK 18.15 (2700) vs 2680 (TLKM)*
US 10yr +0.0190 +2.81% 0.6960
INDO 10yr +0.0051 +0.07% 7.0357
INDO CDS (5yr) +2.043 +1.84% 113.368
IDR (Spot) 14,864.5

*IDX Range : 4,885 - 4,967*
*USD/IDR Range: 14,780 - 14,920*

D. STOCK WATCHLIST

BRPT, BSDE, PRDA, MYOR, MIKA, INAF, KLBF, BBRI, JPFA, BBNI.

DISCLAIMER ON
GFS ASIA TEAM

• 0
• 0
• just now
• 0